New Drugs Archive

FDA Approves Merck’s Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Appropriate Patients

FDA Approves Merck’s Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Appropriate Patients Print this page KENILWORTH, N.J.–(BUSINESS WIRE) August 30, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that …